44 results
Page 2 of 3
6-K
EX-99.1
twxz6eiuqwopd
5 May 21
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
8:45am
20-F
lopm puo16w5k
30 Apr 21
Annual report (foreign)
12:53pm
6-K
EX-99.1
oj0o295 e7j1ytavz
20 Jan 21
Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6:30am
424B4
y9qpojgc5 03232riicb
14 Jan 21
Prospectus supplement with pricing info
9:30am
F-1/A
fa78u sco32b7v
12 Jan 21
Registration statement (foreign) (amended)
12:00am
F-1
jao0nj
8 Jan 21
Registration statement (foreign)
4:58pm
DRS
z2kfr
18 Dec 20
Draft registration statement
12:00am
6-K
EX-10.1
jc5paz8
9 Dec 20
Current report (foreign)
4:23pm
6-K
EX-99.1
x8k45sxt6ids
9 Sep 20
Amryt Announces Positive Top Line Results from Pivotal Phase 3 “Ease” Trial of Filsuvez(r) In Epidermolysis Bullosa
8:23am
424B4
z8rhhs
8 Jul 20
Prospectus supplement with pricing info
4:05pm
F-1/A
umzof3vm
6 Jul 20
Registration statement (foreign) (amended)
5:28pm
F-1
EX-10.5
cm9yn513s1vfr9
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.1
hws0iu8baegzazvv
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.3
kspkao
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-2.2
s4d94i
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
14zyw
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.7
c6l9hwck9wnanheh5ti6
23 Jun 20
Registration statement (foreign)
5:21pm
F-1
EX-10.2
gbqoi hht
23 Jun 20
Registration statement (foreign)
5:21pm
DRS/A
9il1u19ogl92x
29 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
fh0x dq7tsugh15xt
11 May 20
Draft registration statement (amended)
12:00am